From Patents to Public Health: The GLP-1 Journey
Update: 2025-10-20
Description
In this insightful episode, host Lucy Chard is joined by Aurelio Arias from IQVIA to explore the transformative role of GLP-1 therapies in clinical obesity treatment and the technological advancements driving their success. Aurelio delves into how these medications are revolutionising care, offering hope to millions worldwide. A key focus is the upcoming patent expiry of semaglutide in 2026, which could significantly impact affordability and global access, sparking discussions on equitable distribution.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
